Australia Further Delays Cutback In IV Chemo Coverage
This article was originally published in PharmAsia News
Australia's Health Ministry has decided to extend the Sept. 1 effective date for cutbacks in federal support for intravenous chemotherapy drugs. The delay is the third for the plan to cover only the amount used by a patient for a specific treatment rather than covering the cost of a full vial of the drug. The change was to have taken effect July 1 and then was delayed until Sept. 1, but Minister Nicola Roxon said the effective date would be sometime later, on a date yet to be selected. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.